News

Trophea

15 February, 2017

Trophea is addressing the medical need for an effective treatment of skin atrophy caused by long-term use of topical glucocorticoids. The project is based on an innovative combination of two well-known and studied ingredients that seem to offer positive synergistic efficacy on skin atrophy. The preclinical phase is completed and work is ongoing to prepare for a Phase 1 study.

Follow us on

Media contact

Sarah Fredriksson

CEO

Phone:
+46 (0)70 261 4575

Email:
sarah.fredriksson@pulsinvest.se